# Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)

> **NCT07421804** · NA · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** topical dutasteride

## Key facts

- **NCT ID:** NCT07421804
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-04
- **Final completion:** 2028-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07421804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07421804, "Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07421804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*